Association of Inflammatory Factors with Cervical Cancer: A Bidirectional Mendelian Randomization
Qi Li,Liu Kaidong,Zhiyu Tian,Weihua Diao,Yuhong Sun,Ying Bai,Yueyue Ma,Yimiao Wei,Jiarong Li,Weihong Zhao
DOI: https://doi.org/10.2147/jir.s493854
IF: 4.5
2024-12-01
Journal of Inflammation Research
Abstract:Qi Li, 1, 2, &ast Liu Kaidong, 3, &ast Zhiyu Tian, 4 Weihua Diao, 1, 2 Yuhong Sun, 1, 2 Ying Bai, 1, 2 Yueyue Ma, 4 Yimiao Wei, 1, 2 Jiarong Li, 4 Weihong Zhao 1, 4 1 Department of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China; 2 The Second Clinical Medical College, Shanxi Medical University, Taiyuan, People's Republic of China; 3 Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, People's Republic of China; 4 Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Weihong Zhao, Department of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, No. 182 Wuyi Road, Taiyuan, 030001, People's Republic of China, Email Purpose: Persistent human papillomavirus infection is thought to be the main cause of the cervical cancer development along with inflammation. However, the potential mechanisms of action of the inflammatory factors in cervical cancer remain unclear. Therefore, this study aimed to assess the relationship between inflammatory factor levels and cervical cancer risk using a two-sample bidirectional Mendelian randomization (MR). Patients and Methods: MR utilizes single nucleotide polymorphisms as a tool to infer potential causal relationships between exposure factors and outcomes. Datasets for 91 inflammatory factors and cervical cancer were obtained from publicly available pooled data. The inverse variance weighted method was used as the main method and MR-Egger, weighted median, simple mode, and weighted mode were used as auxiliary analyses. Results were tested for robustness using sensitivity tests. In addition, we assessed the possibility of reverse causality between cervical cancer and the derived inflammatory factors by performing a reverse MR analysis. Finally, a preliminary experimental validation was performed. Results: We found that artemin and monocyte chemoattractant protein-4 levels were significantly correlated with elevated cervical cancer risk (β: 0.0024, P = 0.002 and β: 0.0010, P = 0.016, respectively. In contrast, interleukin-18 and interleukin-22 receptor subunit alpha-1 levels were associated with reduced risk of cervical cancer (β: − 0.0010, P = 0.029 and β: − 0.0021, P = 0.046, respectively). Sensitivity analyses were more robust as no significant heterogeneity or horizontal pleiotropy was observed. Conclusion: A significant causal relationship was found between the four inflammatory factors and the risk of cervical cancer, providing new evidence of their clinical implications in cervical cancer diagnosis and treatment. Keywords: ARTN, CCL13, cervical cancer, human papillomavirus, IL-18, IL-22RA1, inflammatory factors, Mendelian randomization Cervical cancer is a common malignant tumor in women and ranks high in the number of cases and deaths globally, particularly in developing countries. Thus, it poses a serious threat to women's health and quality of life. High-risk human papillomavirus (HR-HPV) infection is an important factor in the development and progression of cervical cancer. 1 When cervical cells are exposed to chronic inflammation caused by HR-HPV over a long period of time, the risk of developing cancer increases. 2 Only less than 1–4% patients with persistent HPV infection eventually develop cervical pre-cancer and cancer; it takes about 10–20 years from infection to cervical cancer. 3 During this period, the host immune system fights to clear the virus. However, when the host's immune response is weak, it fails to clear the virus in a timely manner resulting in recurrent inflammation. Repeated cyclic stimulation of inflammatory factors can lead to malignant transformation of normal cells and cause tumor neovascularization, promoting cervical carcinogenesis. 4–6 Among them, many inflammatory factors play a key role in the development of cervical cancer. For example, Interleukin-2 (IL-2) can suppress the immune response by Treg cells, while promoting cell proliferation in the presence of low levels of IL-2. 7 Interleukin-17A (IL-17A) is highly expressed in cervical cancer, promoting M2 macrophage polarization and enhancing cancer cell proliferation, migration and invasion. 8 Thus, reducing inflammation can ef -Abstract Truncated-
immunology